Lunai Bioworks Inc. (LNAI): Cash & Equivalents
$1.71M
As of 2026-06-30
-2.9%
3-year compound annual growth
-39.2%
5-year compound annual growth
n/m
10-year compound annual growth
| Period ended | Cash & Equivalents | Change YoY | Source filing |
|---|---|---|---|
| 2026-06-30 | $1.71M | n/m | 2026-10-13, Balance as of period end |
| 2025-06-30 | $92.7K | -58.0% | 2026-10-13, Balance as of period end |
| 2024-06-30 | $220.5K | -88.2% | 2025-09-29, Balance as of period end |
| 2023-06-30 | $1.87M | -79.6% | 2025-02-19, Balance as of period end |
| 2022-06-30 | $9.17M | -55.6% | 2023-10-02, Balance as of period end |
| 2021-06-30 | $20.66M | +137.6% | 2023-02-27, Balance as of period end |
| 2020-06-30 | $8.70M | -29.2% | 2021-09-24, Balance as of period end |
| 2019-06-30 | $12.28M | -21.3% | 2020-09-23, Balance as of period end |
| 2018-06-30 | $15.60M | +295.8% | 2019-09-30, Balance as of period end |
| 2017-06-30 | $3.94M | n/m | 2018-10-01, Balance as of period end |
| 2016-06-30 | $23.4K | -94.5% | 2017-11-20, Balance as of period end |
| 2015-06-30 | $421.1K | n/a | 2016-09-28, Balance as of period end |
| 2014-12-31 | $3.01M | n/a | 2016-09-28, Balance as of period end |
Cash & Equivalents at similar companies
| Company | Year ended | Cash & Equivalents | Change YoY |
|---|---|---|---|
| Lunai Bioworks Inc. (LNAI) | 2026-06-30 | $1.71M | n/m |
| HCW Biologics Inc. (HCWB) | 2025-12-31 | $1.95M | -58.2% |
| Avalo Therapeutics, Inc. (AVTX) | 2025-12-31 | $15.86M | -88.2% |
| Connect Biopharma Holdings Ltd (CNTB) | 2025-12-31 | $38.34M | -51.0% |
| Inovio Pharmaceuticals, Inc. (INO) | 2025-12-31 | $44.27M | -32.7% |
| Altimmune, Inc. (ALT) | 2025-12-31 | $43.76M | +18.5% |
| Neonc Technologies Holdings, Inc. (NTHI) | 2025-12-31 | $58.7K | -9.5% |
| Silo Pharma, Inc. (SILO) | 2025-12-31 | $4.75M | +21.6% |
| Lyell Immunopharma, Inc. (LYEL) | 2025-12-31 | $60.18M | -43.0% |
Compare LNAI, HCWB, AVTX, CNTB side by side · Screen every company in Pharmaceutical Preparations ↗